Lack of Transferability of Results between Procalcitonin Assays
暂无分享,去创建一个
N. Martin | W. Dhillo | K. Meeran | R. Chapman | R. Ramachandran | M. Donaldson | S. White | P. Benfield
[1] J. V. D. van den Ouweland,et al. Comparison of a new procalcitonin assay from roche with the established method on the brahms kryptor. , 2009, Clinical chemistry.
[2] O. Haas,et al. Sporadic hypercalcitoninemia: clinical and therapeutic consequences. , 2008, Endocrine-related cancer.
[3] E. Cavalier,et al. Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid. , 2008, Clinical chemistry.
[4] C. Bieglmayer,et al. Measurement of calcitonin by immunoassay analyzers , 2007, Clinical chemistry and laboratory medicine.
[5] V. Rohmer,et al. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.